All Issue

2020 Vol.1, Issue 1 Preview Page

January 2020. pp. 12-15
Abstract

Sorry, not available.
Click the PDF button.
References
1 

전립선비대증, 개정판. 대한전립선학회. 일조각. 2015.

2 

전립선비대증 진료권고안, 대한비뇨기과학회/대한배뇨장애요실금학회, 에이플러스기획. 2015.

3 

전립선비대증 진료지침. 대한전립선학회. 메드랑. 2010.

4 

Chung A, Woo HH. Preservation of sexual function when relieving benign prostatic obstruction surgically: can a trade-off be considered? Curr Opin Urol. 2016 Jan;26(1):42-8

10.1097/MOU.000000000000024726555693
5 

Das AK, Leong JY, Roehrborn CG. Office-based therapies for benign prostatic hyperplasia: a review and update. Can J Urol. 2019 Aug;26(4S1):2-7.

6 

Evaluation and nonsurgical management of benign prostatic hyperplasia, Campbell-walsh Urology., 11th edition.

7 

Foster HE, Dahm P, Kohler TS, Lerner LB, Parsons JK, Wilt TJ, McVary KT. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline Amendment 2019. J Urol. 2019 Sep;202(3):592-598.

10.1097/JU.000000000000031931059668
8 

Madersbacher S, Alivizatos G, Nordling J, Sanz CR, Emberton M, de la Rosette JJ. EAU 2004 guideline on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guideline). Eur Urol 2004; 46: 547-554.

10.1016/j.eururo.2004.07.01615474261
9 

McConnell JD, Roehrborn CG, Bautista OM, Andriole GL Jr, Dixon CM, Kusek JW, Lepor H, McVary KT, Nyberg LM Jr, Clarke HS, Crawford ED, Diokno A, Foley JP, Foster HE, Jacobs SC, Kaplan SA, Kreder KJ, Lieber MM, Lucia MS, Miller GJ, Menon M, Milam DF, Ramsdell JW, Schenkman NS, Slawin KM, Smith JA; Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med 2003; 349: 2387-2398.

10.1056/NEJMoa03065614681504
10 

Roehrborn CG, Siami P, Barkin J, Damia˜o R, Major-Walker K, Morrill B, Montorsi F; CombAT Study Group. The effects of dutasteride, tamsulosin and combination therapy on lower urinary tract symptoms in men with benign prostatic hyperplasia and prostatic enlargement: 2-year results from the CombAT study. J Urol 2008; 179: 616 -621.

10.1016/j.juro.2007.09.08418082216
11 

Tran PU, Chung ASJ. Beyond medications: office-based procedures for benign prostatic obstruction. World J Urol. 2019 Jun;37(6):1023-1027.

10.1007/s00345-019-02720-y31037402
Information
  • Publisher :The Association of Korean Urologists
  • Publisher(Ko) :대한비뇨의학과의사회
  • Journal Title :비뇨의학 Urology Digest
  • Volume : 1
  • No :1
  • Pages :12-15